pulmonary-disease

Documents about pulmonary-disease

• The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis#857318ClinicalTrials.gov
• Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation#865628ClinicalTrials.gov
• Phase II Study of RC1416 Injection in COPD#875341ClinicalTrials.gov
• Role of Chest Ultrasound in Detection of Post-operative Pulmonary Complications After Cardiothoracic Surgery#876196ClinicalTrials.gov
• QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt.#881246ClinicalTrials.gov
• Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD#882851ClinicalTrials.gov
• Effect of Ventilation-Feedback Training on Exercise Performance in COPD#886552ClinicalTrials.gov
• Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023#438703Figshare
• Comparative evaluation of molecular technologies for the identification of prevalent non-tuberculous mycobacteria in pulmonary infections: a systematic review and meta-analysis#4637Europe PMC
• Global burden, trends and projections analysis of interstitial lung disease and pulmonary sarcoidosis in elderly adults (aged 55+ Years) based on GBD 2021#120213PLOS
• Burden dynamics of pulmonary arterial hypertension in China and the G20 aggregate: a comparative analysis based on the global burden of disease study 2023#784393Europe PMC
• A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo#883150ClinicalTrials.gov
• PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III#813146ClinicalTrials.gov
• Potential Efficacy of Streptomycin in Amikacin-resistant <i>Mycobacterium avium-intracellulare</i> Complex Pulmonary Disease#156682Unpaywall
• Quantitative label-free multiphoton imaging of collagen features predicts disease severity and progression in idiopathic pulmonary fibrosis.#242244NCBI PubMed Central
• Evaluation of inhaler satisfaction and medication adherence in patients with chronic obstructive pulmonary disease: A cross-sectional study.#250973NCBI PubMed Central
• Impact of smoking on the treatment cycle and health economics of acute exacerbations of chronic obstructive pulmonary disease.#266994NCBI PubMed Central
• Comparative Effectiveness of Telemedicine in Primary Care#267929ClinicalTrials.gov
• A Real-World Evaluation of Therapeutic Inertia in Patients with Severe Uncontrolled Chronic Obstructive Pulmonary Disease.#280911NCBI PubMed Central
• INtervention Study In overweiGHT Patients With COPD#314256ClinicalTrials.gov
• Engagement and Intersectionality in Digital Self-Management Interventions for Asthma and Chronic Obstructive Pulmonary Disease: Scoping Review.#399805NCBI PubMed Central
• Patient journeys mapping in health management for older patients with chronic obstructive pulmonary disease: a qualitative descriptive study.#610201NCBI PubMed Central
• A Phase 2 Trial of JKN24011 in COPD#800634ClinicalTrials.gov
• Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health#811231ClinicalTrials.gov
• Intervention to Improve the Adherence in Community Pharmacies#824928ClinicalTrials.gov
• The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD#825680ClinicalTrials.gov
• Effects of SIMEOX on Static Hyperinflation in Patients With COPD#828122ClinicalTrials.gov
• N-Acetylcysteine for Patients With COPD and ChronicBronchitis#828912ClinicalTrials.gov
• Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate#829654ClinicalTrials.gov
• A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease#830210ClinicalTrials.gov
• Endobronchial Valve for Emphysema Palliation Trial (VENT)#840153ClinicalTrials.gov
• Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction#846518ClinicalTrials.gov
• Non-pharmacological Treatment of Dyspnea in Chronic Obstructive Pulmonary Disease (COPD)#858487ClinicalTrials.gov
• Efficacy of Telemetry-assisted Care in Home Home Vented COPD#867436ClinicalTrials.gov
• Autonomic Function in Patients With COPD#869292ClinicalTrials.gov
• Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects#877093ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD#883007ClinicalTrials.gov
• Early Signs of Altitude Illness in Patients With COPD#883877ClinicalTrials.gov
• Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?#886359ClinicalTrials.gov
• Voices from the Field: Provider Perspectives on the Implementation and Impact of Race-Neutral PFTs#169094DigitalCommons@WayneState
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment#851552ClinicalTrials.gov
• Outcomes of beta-blocker use in people living with chronic obstructive pulmonary disease and a co-existent beta-blocker indicated cardiovascular disease. Insights from a global federated network.#1480NCBI PubMed Central
• Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile#171651HAL (France)
• Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)#181711ClinicalTrials.gov
• The Use of a Forecasting System for Predicting Exacerbations of COPD#848718ClinicalTrials.gov
• Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography#850565ClinicalTrials.gov
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)#845553ClinicalTrials.gov
• The safety window of blood magnesium in pulmonary complications of non-pulmonary sepsis: A U-shaped risk and prognostic analysis based on MIMIC-IV#281564PLOS
• Digital referral experiences within Australian general practice: Insights from Chronic Obstructive Pulmonary Disease (COPD) care as an exemplar.#3745NCBI PubMed Central
• Prediction of Patient Deterioration Using Machine Learning#143702ClinicalTrials.gov